LAURALEE PAKOZDI: Open Payments
NPI 1609889211 · FLEMINGTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,093 in 75 payments from 15 companies in 2025. Trend: 2023 $304 · 2024 $555 · 2025 $1,093
Food & beverage: $1,080Education: $13
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $245 |
| Galderma Laboratories, L.P. | 24 | $231 |
| Janssen Biotech, Inc. | 9 | $144 |
| Organon LLC | 8 | $97 |
| PFIZER INC. | 5 | $78 |
| Novartis Pharmaceuticals Corporation | 3 | $68 |
| Lilly USA, LLC | 2 | $42 |
| UCB, Inc. | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 2 | $32 |
Products named: SKYRIZI, NEMLUVIO, TREMFYA, CIBINQO, COSENTYX, VTAMA, EBGLYSS, AKLIEF.
Industry payments across NJ — which companies pay providers there.
